Iowa Fundamentals of Emergency Medicine

Monday, September 18, 2023, 8:00 AM - Friday, September 22, 2023, 4:00 PM, Emergency Medicine Auditorium (0070 RCP), Iowa City, IA

The University of Iowa Department of Emergency Medicine is proud to offer a unique educational experience for Emergency Medicine providers. The “Iowa Fundamentals of Emergency Medicine” course is a continuing medical education experience unlike any other. Learners will have the opportunity to participate in a variety of educational experiences including lectures, case based small group discussions, procedure labs, and simulation experiences. All of these sessions are taught or facilitated by faculty members in the University of Iowa Department of Emergency Medicine, many with additional training in areas including education, ultrasound, orthopedics/sports medicine, critical care, palliative care, pediatrics and toxicology. Subject areas covered include core concepts of emergency care as well as cutting edge research and advances in the field. The number of learners is limited to facilitate direct
interaction with the faculty, and to encourage group discussions of the various topics covered. This also provider the faculty the opportunity to give individualized attention to the learners. This unique educational environment provides an excellent opportunity for learners and faculty to maximize the impact of the course and improve on inter-professional collaborative practices.

AMA PRA Category 1 Credits™ (31.00 hours), Non-Physician Attendance (31.00 hours), ANCC Contact Hours (31.00 hours)

1. Describe the initial evaluation, diagnostic work-up, treatment, and disposition for commonly encountered and potentially life-threatening chief complaints encountered in emergency medicine.
2. Demonstrate the ability to perform procedures commonly needed in the Emergency Department, including those that are routine and potentially life-saving.
3. Demonstrate the ability to provide appropriate patient care for common and potentially life-threatening chief complaints encountered in emergency medicine in a simulated environment.

Registration fee is $1,150.00.  

 

Refund policy includes a non-refundable cancellation fee of $100.00.  

• Cancellations made prior to 1 month before the course start date: $1,050.00 refund.  
• Cancellations made 2 weeks to 1 month before the course start date: $575.00 refund.
• No refund available for cancellations made less than 2 weeks before the course start date.  

In support of improving patient care, the University of Iowa Roy J. and Lucille A. Carver College of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this live activity for a maximum of 31.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurse: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this live activity for a maximum of 31.00 ANCC contact hours.  Nurses should claim only the credit commensurate with the extent of their participation in the activity. 

Other Provider: All other participants will receive a certificate of participation for this conference upon completion of the online evaluation.  It is the responsibility of each attendee to determine if the continuing education programs they attend meet the requirements of their professional licensure board.

Mitigation of Relevant Financial Relationships

University of Iowa Roy J. and Lucille A. Carver College of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships have been mitigated prior to the commencement of the activity.